Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-27

FDA Approved: TRANYLCYPROMINE — Original Application (Solco Healthcare US, LLC)

View source ↗

Summary

FDA approves an original application for generic tranylcypromine, a monoamine oxidase inhibitor used for major depressive disorder, manufactured by Solco Health…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tranylcypromine (tranylcypromine)

Snippet

ORIG AP for TRANYLCYPROMINE (TRANYLCYPROMINE)